knowledge -WSS

knowledge

author：Wikipedia 2025-09-05 11:30:43 - browse：7138

novavax photo illo — JUSTIN TALLIS/AFP via Getty Images

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, all. Damian here with an update on the plight of the other Covid-19 vaccine company, Wall Street’s latest GLP-1 trade, and the quest for a universal antivenom.

The need-to-know this morning

Ocular Therapeutics announced a shakeup of its senior management team and a $325 million private placement.
Amylyx Therapeutics said results from a closely followed Phase 3 study of its treatment for ALS could come before the start of the second quarter — earlier than previously expected.
Moderna earnings are here.

Novavax’s money is going in the wrong direction

The good news for Novavax is that it’s no longer facing a $700 million dispute with a global charity organization. The bad news is that settling that dispute will force the struggling company to pay out $400 million over the next five years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

focus

leisure time

WSS

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Data integrity in scientific journals requires "effort" by publishers, institutions

Readout LOUD podcast: possible new ALS drug, artificial wombs

Data integrity in scientific journals requires "effort" by publishers, institutions

Why are Kaiser Permanente staff considering a strike?

With measles on the rise, a personal story of a devastating disease

focus

knowledge

The need-to-know this morning

Novavax’s money is going in the wrong direction

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

Thermo Fisher plant for manufacturing gene therapies to expand

Activists slam private health insurers over coverage restrictions

Readout LOUD podcast: Live from STAT Breakthrough Summit West

In Memoriam: Notable people who died in 2023

Solving academic medical centers' existential crisis

DIEP, the 'gold standard' of breast reconstruction, is under threat

Experts study whether long Covid risk adds up with each reinfection

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Changes to biosimilar regulatory framework must prioritize patients

explore

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Military medical care influenced by rank and race, new study finds

Addiction experts warn against a second 'war on drugs'

Intarcia’s device

Changes to biosimilar regulatory framework must prioritize patients

leisure time

focus

leisure time

hotspot